Data published today by the HDA Research Foundation reveal an estimated 93 percent of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion.
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the announcement by the Department of Health and Human Services (HHS) of an interim final rule to implement a “Most Favored Nation Model” for Medicare Part B and a final rule eliminating the prescription drug rebate system for Medicare Part D.
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
A survey released today by the Healthcare Distribution Alliance (HDA) Research Foundation indicates the pharmaceutical supply chain continues to make steady progress to comply with the 2013 Drug Supply Chain Security Act (DSCSA); however, some implementation priorities have shifted amid the initial industry response to the COVID-19 pandemic.
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding the Drug Enforcement Administration’s (DEA) proposed rule on suspicious orders.
